Sign in

CIK 0001868279

  • Non-accelerated filer
  • Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-01-30 HEALY JAMES Director Conversion +1,252,308 1,252,308
2024-01-30 HEALY JAMES Director Purchase +444,444 $18.00 $8.0M 1,696,752
2024-01-30 HEALY JAMES Director Conversion · Series B Preferred Stock −1,252,308 0

Page 1 of 1 · 3 trades